Multiple sclerosis: Clinical features and MRI findings in Northern China

European Journal of Medical Research

Volumn 19, Issue 1, 2014, Pages

  Li, Tianran ^a   Xiao, Hui ^b   Li, Shengjun ^c   Du, Xiangke ^d   Zhou, Jun ^a  

^a No1 Affiliated Hospital of Fuzhou General Hospital of Nanjing Military Corrmand   (China)

^b FUZHOU GENERAL HOSPITAL   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

^d PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Conventional multiple sclerosis; Magnetic resonance imaging; Multiple sclerosis; Optic spinal cord multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANUS SPHINCTER DISORDER; ARTICLE; ATAXIA; BLURRED VISION; BRAIN ATROPHY; CHINA; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CONVENTIONAL MULTIPLE SCLEROSIS; DIPLOPIA; DISEASE CLASSIFICATION; DYSARTHRIA; EXPANDED DISABILITY STATUS SCALE; FEMALE; HEALTH SURVEY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NYSTAGMUS; OPTIC SPINAL MULTIPLE SCLEROSIS; PARESTHESIA; RECURRENCE RISK; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; SPINAL CORD DISEASE; SPINAL CORD LESION; SPINAL CORD SWELLING; WEAKNESS; CLASSIFICATION; DISABILITY; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHINA; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84899981084     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-19-20     Document Type: Article

References (23)

1. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Osoegawa M, Kira J, Fukazawa T, Fujihara K, Kikuchi S, Matsui M, Kohriyama T, Sobue G, Yamamura T, Itoyama Y, Saida T, Sakata K, Ochi H, Matsuoka T, Mult Scler 2009 15 159 173 18987106
2. Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Lau KK, Wong LK, Li LS, Chan YW, Li HL, Wong V, Hong Kong Med J 2002 8 77 80 11937660
3. Multiple sclerosis amongst Chinese in Hong Kong. Yu YL, Woo E, Hawkins BR, Ho HC, Huang CY, Brain 1989 112 1445 1467 10.1093/brain/112.6.1445 2597990
4. The diagnostic and classificatory criteria of multiple sclerosis. Xu XH, Qiao LY, Zhang H, Wang YJ, Zhang XH, Guo XD, Zhang WW, Li J, Xie RP, Li XG, Wang YH, Hao HJ, Yin L, Qi XK, Wang XQ, Ma WY, Jing J, Li J, Sun YH, Yan LR, Chen TF, Wang DX, Song DL, Lv Y, Chin J Neuroimmunol & Neurol 2001 8 134 138
5. Classification of MS and treatment strategy. Matusui M, Nihon Rinsho 2008 66 1112 1116 18540356
6. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS, Ann Neurol 2001 50 121 127 10.1002/ana.1032 11456302
7. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. Swanton JK, Fernando K, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT, Miller DH, J Neurol Neurosurg Psychiatry 2006 77 830 833 10.1136/jnnp.2005.073247 16043456
8. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Lublin FD, Reingold SC, Neurology 1996 46 907 911 10.1212/WNL.46.4.907 8780061
9. Relapses and progression of disability in multiple sclerosis. Confavreux C, Vukusic S, Moreau T, Adeleine P, N Engl J Med 2000 343 1430 1438 10.1056/NEJM200011163432001 11078767
10. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, Kawano Y, Hasuo K, Tobimatsu S, Kobayashi T, Ann Neurol 1996 40 569 574 10.1002/ana.410400405 8871575
11. Revised diagnostic criteria for neuromyelitis optica. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, Neurology 2006 66 1485 1489 10.1212/01.wnl.0000216139.44259.74 16717206
12. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Mealy MA, Wingerchuk DM, Greenberg BM, Levy M, Arch Neurol 2012 69 1176 1180 22733096
13. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Kurtzke JF, Neurology 1983 33 1444 1452 10.1212/WNL.33.11.1444 6685237
14. MRI criteria for MS in patients with clinically isolated syndromes. Montalban X, Tintoré M, Swanton JK, Barkhof F, Fazekas F, Filippi M, Frederiksen J, Kappos L, Palace J, Polman C, Rovaris M, de Stefano N, Thompson A, Yousry T, Rovira A, Miller DH, Neurology 2010 74 427 434 10.1212/WNL. 0b013e3181cec45c 20054006
15. Multiple sclerosis in the Japanese population. Kira J, Lancet Neurol 2003 2 117 127 10.1016/S1474-4422(03)00308-9 12849268
16. Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. Ishizu T, Kira J, Osoegawa M, Fukazawa T, Kikuchi S, Fujihara K, Matsui M, Kohriyama T, Sobue G, Yamamura T, Itoyama Y, Saida T, Sakata K, J Neurol Sci 2009 280 22 28 10.1016/j.jns.2009.01.008 19201428
17. Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study. Chang KH, Lyu RK, Chen CM, Hsu WC, Wu YR, Chen ST, Ro LS, Mult Scler 2006 12 501 506 10.1191/1352458506ms1297oa 16900765
18. The natural history of multiple sclerosis: a geographically based study. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC, Brain 1989 112 1419 1428 10.1093/brain/112.6.1419 2597989
19. HLA-DPB1 + 0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, Yamada T, Mihara F, Ito H, Nishimura Y, Kira J, Brain 1999 122 1689 1696 10.1093/brain/122.9.1689 10468508
20. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. Fukazawa T, Kikuchi S, Sasaki H, Hamada K, Hamada T, Miyasaka K, Tashiro K, J Neurol Sci 1998 158 209 214 10.1016/S0022-510X(98)00127-0 9702693
21. Cerebrospinal fluid IgG profiles and multiple sclerosis in Japan. Fukazawa T, Moriwaka F, Sugiyama K, Hamada T, Tashiro K, Acta Neurol Scand 1993 88 178 183 10.1111/j.1600-0447.1993.tb03435.x 8256553
22. Role of MRI in diagnosis and treatment of multiple sclerosis. Sahraian MA, Eshaghi A, Clin Neurology Neurosurg 2010 112 609 615 10.1016/j.clineuro. 2010.03.022
23. Identification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging. Mike A, Glanz BI, Hildenbrand P, Meier D, Bolden K, Liguori M, Dell'Oglio E, Healy BC, Bakshi R, Guttmann CRG, Am J Neuroradiol 2011 32 515 521 10.3174/ajnr.A2340 21310857